Sptrx-1 is the first member of the thioredoxin family of proteins with a tissuespecific expression pattern, found exclusively in the tail of elongating spermatids and spermatozoa. We describe here further biochemical characterization of human Sptrx-1 protein structure and enzymatic activity. In gel filtration chromatography human Sptrx-1 eluates as a 400 kDa protein consistent with either an oligomeric form, not maintained by intermolecular disulfide bonding, and/or a highly asymmetrical structure. Analysis of circular dichroism spectra of fragments 1-360 and 361-469 and comparison to spectra of full length Sptrx-1 supports a two domain organization with a largely unstructured Nterminal domain and a folded Trx-like C-terminal domain. Functionally, Sptrx-1 behaves as an oxidant in vitro when using selenite, but not oxidized glutathione, as electron acceptor. This oxidizing enzymatic activity suggests that Sptrx-1 might govern the stabilization (by disulfide cross-linking) of the different structures in the developing tail of spermatids and spermatozoa. 
INTRODUCTION
In sexually reproducing species the fusion of the gametes is a prerequisite for the generation of the offspring whose genetic makeup is different from both parents. This mode of reproduction via fertilization emerged during evolution and has been maintained in most metazoans including mammals. [1] . In higher vertebrates the complexity of the fertilization process is increased by the advent of internal fertilization and by the functional adaptations of the oocyte vestments. To circumvent associated difficulties, the spermatozoon has acquired a highly specialized morphology consisting of cytoskeletal components, which appear to have no structural counterparts in somatic cells [2] . The most evident among these cytoskeletal structures are the perinuclear theca (PT) of the sperm head and the outer dense fibers (ODF) and fibrous sheath (FS) of the sperm tail [3] . The mammalian ODF and FS are composed of numerous polypeptides of which only a few have been cloned and characterized to date (reviewed in [4] ). ODF and FS are believed to regulate the beat of the sperm flagella by adding stiffness, elastic recoil and protection against shearing forces generated during sperm transit through epididymis [5] . However, there is increasing evidence for a more active role of ODF and FS in sperm function than merely structural, also supported by the fact that among their constituent proteins there are a few displaying either enzymatic or regulatory functions.
Thioredoxins are a class of multifunctional protein disulfide reductants that participate in different cellular processes by the reversible oxidation of cysteine residues in their conserved active site Cys-Gly-Pro-Cys. Thioredoxins have both intracellular and extracellular roles such as electron donor for ribonucleotide reductase, regulator of cell growth and apoptosis, embryonic implantation, modulator of the DNA binding activity of transcription factors, co-cytokine and as protective mechanism against oxidative stress (reviewed in [6, 7] ). In the human genome, three ubiquitous forms of thioredoxins have been identified so far: Trx-1, a cytosolic enzyme that can translocate into the nucleus upon certain stimuli [7] ; Trx-2, a mitochondrial enzyme [8] and Txl-1/Trp32, a protein with no function described so far [9, 10] . In addition, we have recently identified two novel members of the thioredoxin family, named Sptrx-1 and Sptrx-2, whose expression is restricted to the haploid phase of spermatogenesis [11, 12] . Sptrx-1 transiently associates to the longitudinal columns of the FS during sperm tail assembly but does not remain as a permanent component of the FS in the mature sperm [4] . In turn, Sptrx-2 is a structural component of the mature FS (R. Oko and A. Miranda-Vizuete, unpublished results). Sptrx-1 and Sptrx-2 represent the first two members of the family with tissuespecific distribution and interestingly, both located in close association to the sperm fibrous sheath. We present here evidence that Sptrx-1 is organized into two independent structural domains: a 38.7 kDa unstructured polypeptide (residues 1-357) and a 12.7 kDa Trx-like domain (residues 358-469). Characterization of Sptrx-1 in vitro suggests that the protein behaves as a non-covalent oligomer in solution and that this organization might modulate its redox properties. The implications of an oxidizing character of Sptrx-1 are discussed in the light of its unique expression pattern during sperm tail formation.
MATERIALS AND METHODS
Expression and purification of human Sptrx-1. The ORF encoding human Sptrx-1 was cloned into the BamHI-EcoRI sites of the pGEX-4T-1 expression vector and transformed in E. coli BL21(DE3). The induction of the fusion protein was performed as previously described [11] . Briefly, overexpressing cells were disrupted by 10 min sonication and the supernatant was cleared by centrifugation at 15,000 x g for 30 min and loaded onto a glutathione sepharose 4B column (Amersham Pharmacia Biotech). Binding to the matrix was allowed to occur during 2 h at room temperature. Thrombin (5U per mg fusion protein) was used to remove GST by incubation overnight at 4°C. The resulting protein preparation was then subjected to ion exchange chromatography using a HiTrap Q column (Amersham Pharmacia Biotech) and human Sptrx-1 was eluted using a gradient of NaCl. Protein concentration was determined from the absorbance at 280 nm Circular dichroism spectroscopy. Circular dichroism spectroscopy was performed using an Aviv 202DS spectropolarimeter (Lakewood, NJ). Spectra were obtained using protein solutions in 100 mM potassium phosphate buffer pH 7.0 containing 10 mM NaCl and 1 mM EDTA at protein concentrations ranging from 0.5 to 0.9 mg/ml at 25 °C in 0.01 cm cuvettes. Spectra were recorded for 8 seconds per nm between 260 and 184 nm.
Protein concentrations were determined by quantitative amino acid analysis [15] .
Contributions from cuvette and solvent were removed by subtracting an identically recorded spectrum of buffer without protein. No signal processing (e.g. smoothing) was used.
Enzymatic activity assays. Disulfide bond formation was measured in a reduced model peptide, NRCSQGSCWN, (Genemed Synthesis) which was acetylated and amidated at the N-and C-terminus, respectively by the manufacturer essentially as described [16, 17] . The peptide concentration was calculated using the molar extinction Control experiments were performed using fully oxidized and reduced peptide.
RESULTS
Oligomeric structure of human Sptrx-1. In addition to the two cysteine residues in the active site of the thioredoxin domain, human Sptrx-1 has four additional cysteine residues located in the C-terminal thioredoxin domain [11] . Interestingly, when determining the thioredoxin activity of recombinant Sptrx-1 we observed that prior reduction of the protein by DTT diminished its activity, in contrast to what happens to Trx-1. Previously, we showed that Sptrx-1 migrated anomalously (~180 kDa) on nondenaturing PAGE thus suggesting a possible oligomeric form [11] . In an attempt to further define the oligomeric state of Sptrx-1 in vitro, we first performed gel filtration domains are combined and compared to that of full-length Sptrx-1 (Fig. 4) , the close coincidence of the two spectra is strong evidence that the two domains do not influence each others structure significantly, supporting the picture of a largely disordered Nterminal domain and a folded C-terminal Trx-like domain.
Redox activity of human Sptrx-1 protein.
We have previously reported a weak reducing activity of human recombinant Sptrx-1 using both DTT or NADPH and thioredoxin reductase as electron donors [11] . We sought to determine whether human Sptrx-1 might in fact be capable of catalysing disulfide bond formation, in vitro. For this purpose, a model peptide whose oxidized and reduced forms can be separated by HPLC after reaction with Sptrx-1 or PDI was used. For a functional assay, an electron acceptor is also needed. Oxidized glutathione (GSSG) is a common oxidant of protein thiols.
corresponding to -202 mV, no activity could be detected by Sptrx-1 (Figure 5a ). In the presence of selenite (which is known to oxidize the active site of Trx-1 in a nonstoichiometric and oxygen dependent manner [21] ) Sptrx-1 oxidized the peptide at a similar initial rate compared to PDI but with a lower final yield (Figure 5b ). Similar results were obtained using fluorometric and colorimetric assays with GSSG and selenite (data not shown).
DISCUSSION
The transformation of spermatids to spermatozoa (spermiogenesis) involves a complex sequence of events by which a conventional cell is converted into a highly organized motile structure. During spermiogenesis the spermatid undergoes striking and unique morphological and biochemical changes that include nuclear condensation, acrosome formation and sperm tail organization [22] . A common link for most of these processes to occur is a progressive increase in disulfide bonding, which starts at the spermatid stage and continues through epididymal transit [23] [24] [25] [26] . However, despite the prominent role of disulfide bonding in spermiogenesis, the molecular mechanisms that regulate this process are still poorly understood, mostly due to the lack of in vitro models of spermiogenesis.
Thioredoxins are a class of proteins typically considered as key players in redox regulated cellular mechanisms [7] . Sptrx-1 is the first member of this family with a tissuespecific distribution, located in the sperm tail [11] . A developmental expression analysis through the spermatogenic cycle in rodents has shown that Sptrx-1 transiently associates to the longitudinal columns of the sperm FS during its elongation and assembly but does not remain as a structural component of the FS in the mature sperm [4] . When analysing Sptrx-1 thioredoxin activity in the presence of NADPH and thioredoxin reductase we found that preincubation of the protein with DTT (to fully reduce the protein) resulted in a decrease of the activity compared to that of oxidized Sptrx-1, in contrast to what occurs to Trx-1 used as control [11] . This data suggested an important role of the cysteine residues for the maintenance of Sptrx-1 in an active conformation. We decided to further FS is a spermatozoa cytoskeletal structure, with no counterpart in somatic cells, characterized by its elastic rigidity to provide support to the sperm tail during its beating [27] . This function is dependent on the tight association of the proteins that integrate the FS, achieved through extensive disulfide bonding and resulting on its high insolubility.
As we have demonstrated, Sptrx-1 is able to function as a reductant as well as an oxidant in vitro. Together with its spatial and temporal expression in the tail of elongating spermatids simultaneous to the assembly of the FS, our data suggests that Sptrx-1 could indeed participate in the regulation of this process by favouring the formation of disulfide bonds during sperm tail morphogenesis. In addition, its dual reducing/oxidizing activity might be required to rectify non-correct disulfide pairing and generate the suitable ones between the different sperm FS constituents, similarly to what occurs to the disulfide bond reshuffling activity of PDI [28] . The relatively mild reducing and oxidizing activities of recombinant Sptrx-1 should be viewed in a wider substrate could be limited by the reoxidation of Sptrx-1. In the case of PDI and the protein DsbA, this has been shown to be the rate-limiting step in similar experiments [16, 29] . Second, it is plausible that additional factors are required in the assay, most probably testis-specific, or post-translational modifications might be necessary to achieve a fully active protein. Third, higher activity could be obtained upon interaction with substrates. In this context, the N-terminal domain, which is unstructured in solution, could acquire a more structured conformation after binding to an interacting protein.
As noted previously, the morphogenesis and assembly of FS (as well as other components of sperm tail) require stabilization by disulfide bonding between its different constituent proteins. Therefore, failure of proper functioning of Sptrx-1 could lead to spermatozoa tail defects, thus justifying further work on Sptrx-1 as a potential target for male factor infertility studies. 
